Archive March 14, 2023 Deciphera Pharmaceuticals Announces Eight Presentations Highlighting Discovery Research Programs at the American Association for Cancer Research (AACR) Annual Meeting 2023
Archive March 1, 2023 Deciphera Pharmaceuticals Announces Completion of Enrollment for Pivotal Phase 3 MOTION Study of Vimseltinib in TGCT
Archive February 7, 2023 Deciphera Pharmaceuticals Announces Fourth Quarter and Full Year 2022 Financial Results
Archive January 31, 2023 Deciphera Pharmaceuticals to Announce Fourth Quarter and Full Year 2022 Financial Results and Host Conference Call and Webcast on February 7, 2023
Archive January 24, 2023 Deciphera Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
Archive January 24, 2023 Deciphera Pharmaceuticals Presents Results from ctDNA Analysis of INTRIGUE Phase 3 Clinical Study at the American Society of Clinical Oncology Plenary Series Session
Archive January 19, 2023 Deciphera Pharmaceuticals Announces Pricing of Public Offering of Common Stock
Archive January 18, 2023 Deciphera Pharmaceuticals Announces Proposed Public Offering of Common Stock
